Adolescent MenACWY Booster Study

Exclusion Criteria

• •The participant may not enter the trial if ANY of the following apply:
• •1. Has already received any doses of MenACWY vaccine at any age
• •2. Previous confirmed or suspected meningococcal disease
• •3. Close contact with an individual with laboratory-confirmed N. meningitidis in prior 12 months
• •4. Previous allergic reaction to a component of any of the 3 vaccines
• •5. Serious chronic or progressive disease
• •6. Confirmed/suspected immunodeficiency
• •7. Receipt of more than 1 week of immunosuppressants or immune modifying drugs (e.g. oral prednisolone \>0.5mL/kg/day or intravenous glucocorticoid steroid). Nasal, topical or inhaled steroids are allowed
• •8. Administration of immunoglobulins within the prior 12 months and/or any blood products planned during the study period
• •9. Pregnancy (based on history from adolescent and parent/legal guardian)
• •10. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.